354 related articles for article (PubMed ID: 18976288)
1. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
2. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
4. Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas.
Ericksen T; Mauldin N; Dickinson R; Mauldin G
J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37437890
[TBL] [Abstract][Full Text] [Related]
5. Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.
Setyo L; Ma M; Bunn T; Wyatt K; Wang P
Vet Comp Oncol; 2017 Dec; 15(4):1468-1478. PubMed ID: 28194917
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.
Harper A; Blackwood L
J Small Anim Pract; 2017 Apr; 58(4):227-230. PubMed ID: 28133740
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of variables associated with outcomes in 41 dogs with incompletely excised high-grade soft tissue sarcomas treated with definitive-intent radiation therapy with or without chemotherapy.
Crownshaw AH; McEntee MC; Nolan MW; Gieger TL
J Am Vet Med Assoc; 2020 Apr; 256(7):783-791. PubMed ID: 32176583
[TBL] [Abstract][Full Text] [Related]
8. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
[TBL] [Abstract][Full Text] [Related]
9. Long-Term outcome following surgical excision of large, low to intermediate grade soft tissue sarcomas in dogs.
Davis A; Hosgood G
Aust Vet J; 2023 May; 101(5):193-199. PubMed ID: 36751015
[TBL] [Abstract][Full Text] [Related]
10. Scar revision for incompletely or narrowly excised soft tissue sarcomas in dogs.
Grimes JA; Rajeev M; Wallace ML; Laver T; Milovancev M
Can Vet J; 2023 Jan; 64(1):70-75. PubMed ID: 36593932
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs.
Gagnon J; Mayer MN; Belosowsky T; Mauldin GN; Waldner CL
J Am Vet Med Assoc; 2020 Jan; 256(1):102-110. PubMed ID: 31841095
[TBL] [Abstract][Full Text] [Related]
12. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.
Milovancev M; Townsend KL; Bracha S; Gorman E; Curran K; Russell DS
Vet Surg; 2018 Jan; 47(1):36-43. PubMed ID: 29064583
[TBL] [Abstract][Full Text] [Related]
13. Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study.
Paulos PE; Boston S; Skinner OT; Liptak JM; Amsellem PM; Fournier Q; Wood CJ; Annoni M; Murgia D; Oblak ML; Dean BL; Baird SD; Kulendra NJ
Vet Comp Oncol; 2022 Sep; 20(3):669-678. PubMed ID: 35420253
[TBL] [Abstract][Full Text] [Related]
14. Marginal excision of cutaneous mast cell tumors in dogs was not associated with a higher rate of complications or prolonged wound healing than marginal excision of soft tissue sarcomas.
Cockburn E; Janovec J; Solano MA; L'Eplattenier H
J Am Vet Med Assoc; 2022 Jan; 260(7):741-746. PubMed ID: 35092664
[TBL] [Abstract][Full Text] [Related]
15. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
Alexander CK; Cronin KL; Silver M; Gardner HL; London C
J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
[TBL] [Abstract][Full Text] [Related]
16. Influence of surgical margin completeness on risk of local tumour recurrence in canine cutaneous and subcutaneous soft tissue sarcoma: A systematic review and meta-analysis.
Milovancev M; Tuohy JL; Townsend KL; Irvin VL
Vet Comp Oncol; 2019 Sep; 17(3):354-364. PubMed ID: 30953384
[TBL] [Abstract][Full Text] [Related]
17. A retrospective comparison of carbon dioxide surgical laser and non-laser excision for removal of cutaneous and subcutaneous soft-tissue sarcomas in dogs.
Agulian L; Mann FA; Middleton JR; Kim DY
N Z Vet J; 2020 Nov; 68(6):340-344. PubMed ID: 32529958
[No Abstract] [Full Text] [Related]
18. Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma.
Berthold F; Hömberg M; Proleskovskaya I; Mazanek P; Belogurova M; Ernst A; Sterba J
Pediatr Hematol Oncol; 2017 Aug; 34(5):308-319. PubMed ID: 29148865
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.
Spugnini EP; Vincenzi B; Amadio B; Baldi A
Open Vet J; 2019 Apr; 9(1):88-93. PubMed ID: 31086772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
